BioSpace News Archive

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team are scheduled to participate in three virtual investor conferences in March. Details are as follows:

OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that Alexis Peyroles, Chief Executive Officer, will provide an overview of the Company’s business at the upcoming H.C. Wainwright Global Life Sciences Conference to be held March 9-11, 2021.

Intrommune Therapeutics, a New York-based clinical stage biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and other food allergies, partnered with The Solution Lab (“TSL”) to publish the “Peanut Allergy and Immunotherapy – Treatment Landscape & Future Outlook” white paper.

Perrigo Company plc, a leading global provider of Quality, Affordable Self-Care Products, announced that its Board of Directors approved a 7% increase in the Company’s quarterly dividend to $0.24 per share from $0.225 per share.

Arist, developers of an innovative enterprise-level text messaging platform for education, training and outreach, has announced that its technology has been optimized to better meet the needs of the life sciences industry.

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, updated its communication regarding the withdrawal of its application for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) for the SARS-CoV-2 molecular diagnostic test on its Revogene ® platform.

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, announced the first patients have been enrolled in its clinical study titled, A Randomized, Controlled Study to Evaluate Effectiveness of AlloWrap® Amniotic Membrane for the Reduction of Post-Operative Soft Tissue Inflammation in Two-Level Anterior Cervical Discectomy and Fusion Procedures.

Chicago-based Tyler Prince, Executive Vice President Worldwide Alliances and Channels for Salesforce, has received the first-ever Impact Maker of the Year Volunteer Award from the American Cancer Society, North Central Region.

Brickell Biotech, Inc., a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020, after the market close on Tuesday, March 9, 2021.

Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced it will release financial results for the fourth quarter and full year 2020 after market close on Tuesday, March 9, 2021.